二尖瓣叶缩短作为梗阻性肥厚型心肌病的辅助手术
回顾性研究纳入2010年1月至2020年3月416例接受心肌切除术的梗阻性肥厚型心肌病患者,比较联合二尖瓣叶缩短与单纯心肌切除术的结局。8年累积生存率两组均为95%,生存无差异;术后2.5年超声显示静息和激发压差、二尖瓣反流及左房容积均下降,联合组与单纯组关键变量无差异。作者认为对选定患者二尖瓣缩短可能是合适的手术判断。
要点
- 416例心肌切除术患者,192例(58%)联合二尖瓣叶缩短,医院死亡率0.7%。
- 8年累积生存率联合缩短组与单纯心肌切除组均为95%,两组生存无差异。
- 术后2.5年超声示压差、二尖瓣反流及左房容积下降,联合组与单纯组关键变量无差异。
核心结论
- 作者认为,对选定患者二尖瓣缩短可能是合适的手术判断。
研究设计与样本
- 回顾性研究,纳入2010年1月至2020年3月所有接受心肌切除术的患者,分析生存和超声心动图结果。
- 共416例患者接受心肌切除术,年龄57.5±13.6岁,204例(49%)为女性,平均随访5.4±2.8年,415例完成生存随访。
- 332例接受不伴瓣膜置换的心肌切除术,其中192例(58%)联合二尖瓣叶缩短;二尖瓣叶折叠73例,残余瓣叶切除(ReLex)151例,两种手术均做32例。
- 研究比较心肌切除联合二尖瓣叶缩短与单纯心肌切除术患者的结局。
主要发现
- 心肌切除术患者医院死亡率为0.7%。
- 8年时,心肌切除联合瓣叶缩短组与单纯心肌切除组的累积生存率均为95%,两组生存无差异。
- 前叶折叠组与ReLex组之间生存无差异。
- 术后2.5年超声心动图显示静息和激发压差、二尖瓣反流及左房容积下降,接受辅助瓣叶缩短的患者与单纯心肌切除患者之间关键变量无差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mitral leaflet elongation is common in hypertrophic cardiomyopathy (HCM), contributes to obstructive physiology, and presents a challenge to the dual surgical goals of abolition of outflow gradients and abolition of mitral regurgitation. Anterior leaflet shortening, performed as an ancillary surgical procedure during myectomy, is controversial. METHODS: This was a retrospective study of all patients undergoing myectomy from January 2010 to March 2020, with analysis of survival and echocardiographic results. The study compared outcomes of patients treated with myectomy and concomitant mitral leaflet shortening with patients treated with myectomy alone. Over this time, the technique for mitral shortening evolved from anterior leaflet plication to residual leaflet excision (ReLex). RESULTS: Myectomy was performed in 416 patients aged 57.5 ± 13.6 years, and 204 (49%) patients were female. Average follow-up was 5.4 ± 2.8 years. Survival follow-up was complete in 415 patients. Myectomy without valve replacement was performed in 332 patients, of whom 192 had mitral valve shortening (58%). Mitral leaflet plication was performed in 73 patients, ReLex in 151, and both procedures in 32. Hospital mortality for patients undergoing myectomy was 0.7%. At 8 years, cumulative survival was 95% for both the myectomy combined with leaflet shortening group and the myectomy alone group, with no difference in survival between the 2 groups. There was no difference in survival between the anterior leaflet plication and ReLex groups. Echocardiography 2.5 years after surgery showed a decrease in resting and provoked gradients, mitral regurgitation, and left atrial volume and no difference in key variables between patients who underwent ancillary leaflet shortening and patients who underwent myectomy alone. CONCLUSIONS: These results affirm that mitral shortening may be an appropriate surgical judgment for selected patients.
引用
- Swistel DG, Massera D, Stepanovic A, et al. Mitral Leaflet Shortening as an Ancillary Procedure in Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2024. PMID: 38518836. doi:10.1016/j.athoracsur.2024.03.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。